Moberg strikes MOB-015 deal in South Korea

23 October 2019 - Deborah Wilkes


Moberg Pharma has signed an exclusive South Korean distribution agreement for MOB-015, its novel topical terbinafine formulation for treating nail fungus.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: